Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EXEMESTANE Cause Chronic obstructive pulmonary disease? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Chronic obstructive pulmonary disease have been filed in association with EXEMESTANE (Exemestane). This represents 0.2% of all adverse event reports for EXEMESTANE.

17
Reports of Chronic obstructive pulmonary disease with EXEMESTANE
0.2%
of all EXEMESTANE reports
2
Deaths
12
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From EXEMESTANE?

Of the 17 reports, 2 (11.8%) resulted in death, 12 (70.6%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EXEMESTANE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does EXEMESTANE Cause?

Fatigue (1,122) Malignant neoplasm progression (1,025) Arthralgia (943) Diarrhoea (941) Nausea (913) Neoplasm progression (692) Dyspnoea (673) Malaise (620) Headache (606) Asthenia (597)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which EXEMESTANE Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

EXEMESTANE vs EXENATIDE EXEMESTANE vs EXFORGE EXEMESTANE vs EXJADE EXEMESTANE vs EXTAVIA EXEMESTANE vs EXTRANEAL

Related Pages

EXEMESTANE Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease EXEMESTANE Demographics